General American Investors’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

General American Investors’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-714,100	Closed	-$8.88M	–	65
2016 Q4	$8.88M	Sell	714,100 -43,300	-6%	-$521K	0.9%	44
2016 Q3	$10.4M	Sell	757,400 -442,600	-37%	-$4.44M	1.06%	40
2016 Q2	$8.87M	Hold	1,200,000	–	–	0.92%	42
2016 Q1	$7.67M	Hold	1,200,000	–	–	0.79%	42
2015 Q4	$7.5M	Hold	1,200,000	–	–	0.69%	45
2015 Q3	$7.01M	Hold	1,200,000	–	–	0.63%	48
2015 Q2	$9.92M	Hold	1,200,000	–	–	0.82%	44
2015 Q1	$9.89M	Hold	1,200,000	–	–	0.81%	45
2014 Q4	$8.24M	Hold	1,200,000	–	–	0.66%	49
2014 Q3	$6.48M	Hold	1,200,000	–	–	0.52%	50
2014 Q2	$7.64M	Hold	1,200,000	–	–	0.62%	51
2014 Q1	$9.67M	Hold	1,200,000	–	–	0.81%	47
2013 Q4	$8.18M	Buy	1,200,000 +760,000	+173%	+$4.1M	0.66%	50
2013 Q3	$8.1M	Hold	440,000	–	–	0.7%	47
2013 Q2	$7.7M	Buy	+440,000	New	+$7.8M	0.7%	50

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return

General American Investors's ARIA Position: Q1 2017 in Review

General American Investors sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 714,100 shares — an estimated $8.88M sold.

General American Investors first reported a position in ARIA in Q2 2013 and held it in 15 quarters. The position peaked at $10.4M in Q3 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

General American Investors reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
General American Investors sold 714,100 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $8.88M.
General American Investors first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 15 quarters.
General American Investors's Ariad Pharmaceuticals Inc position peaked at $10.4M in Q3 2016.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on General American Investors's 13F filing for Q1 2017, filed 28 Apr 2017.